JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 13, 2006
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
281/2/807    most recent
M511050200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Datta, S.
Right arrow Articles by Osborne, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Datta, S.
Right arrow Articles by Osborne, T. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print November 9, 2005
J. Biol. Chem, 10.1074/jbc.M511050200
Submitted on October 11, 2005
Revised on November 4, 2005
Accepted on November 9, 2005

Regulation of HMG CoA reductase promoter by nuclear receptors LRH-1 and SHP: A mechanism for differential regulation of cholesterol synthesis and uptake

Shrimati Datta, Li Wang, David D. Moore, and Timothy F. Osborne

Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697-3900

Corresponding Author: tfosborn{at}uci.edu

Cholesterol homeostasis in mammals involves pathways for biosynthesis, cellular uptake and hepatic conversion to bile acids. Key genes for all three pathways are regulated by negative feedback control. Uptake and biosynthesis are directly regulated by cholesterol through its inhibition of the proteolytic activation of the sterol regulatory element binding proteins (SREBPs). Whereas the conversion of cholesterol into bile acids in the liver is regulated through the bile acid dependent induction of the negative acting small heterodimer partner (SHP) nuclear receptor. In this report we show that SHP also directly regulates cholesterol biosynthesis through inhibition of HMG CoA reductase but has no effect on LDL receptor expression. This has significant metabolic significance as it provides both a mechanism to independently regulate cholesterol synthesis from uptake, an essential regulatory feature known to occur in vivo, and a pathway for direct regulation of cholesterol biosynthesis by bile acids. This latter feature ensures that the early phase of bile acid synthesis (pre-cholesterol) is in metabolic communication with the later stages of the pathway to properly regulate whole pathway flux. This highlights an important regulatory feature that is shared with other key branched, multi-enzyme pathways such as glycolysis where pathway outflow through pyruvate kinase is regulated by the concentration of a key early intermediate, fructose 1,6 bisphosphate.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. K. Bennett, Y.-K. Seo, S. Datta, D.-J. Shin, and T. F. Osborne
Selective Binding of Sterol Regulatory Element-binding Protein Isoforms and Co-regulatory Proteins to Promoters for Lipid Metabolic Genes in Liver
J. Biol. Chem., June 6, 2008; 283(23): 15628 - 15637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-J. Shin and T. F. Osborne
Peroxisome Proliferator-activated Receptor-{gamma} Coactivator-1{alpha} Activation of CYP7A1 during Food Restriction and Diabetes Is Still Inhibited by Small Heterodimer Partner
J. Biol. Chem., May 30, 2008; 283(22): 15089 - 15096.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Xu, O. L. Tavares-Sanchez, Q. Li, J. Fernando, C. M. Rodriguez, E. J. Studer, W. M. Pandak, P. B. Hylemon, and G. Gil
Activation of Bile Acid Biosynthesis by the p38 Mitogen-activated Protein Kinase (MAPK): HEPATOCYTE NUCLEAR FACTOR-4{alpha} PHOSPHORYLATION BY THE p38 MAPK IS REQUIRED FOR CHOLESTEROL 7{alpha}-HYDROXYLASE EXPRESSION
J. Biol. Chem., August 24, 2007; 282(34): 24607 - 24614.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. E. Matsukuma, L. Wang, M. K. Bennett, and T. F. Osborne
A Key Role for Orphan Nuclear Receptor Liver Receptor Homologue-1 in Activation of Fatty Acid Synthase Promoter by Liver X Receptor
J. Biol. Chem., July 13, 2007; 282(28): 20164 - 20171.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. L. Hubbert, Y. Zhang, F. Y. Lee, and P. A. Edwards
Regulation of Hepatic Insig-2 by the Farnesoid X Receptor
Mol. Endocrinol., June 1, 2007; 21(6): 1359 - 1369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kanayama, M. Arito, K. So, S. Hachimura, J. Inoue, and R. Sato
Interaction between Sterol Regulatory Element-binding Proteins and Liver Receptor Homolog-1 Reciprocally Suppresses Their Transcriptional Activities
J. Biol. Chem., April 6, 2007; 282(14): 10290 - 10298.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
W. R. Lagor, R. Heller, E. D. De Groh, and G. C. Ness
Functional Analysis of the Hepatic HMG-CoA Reductase Promoter by In Vivo Electroporation
Experimental Biology and Medicine, March 1, 2007; 232(3): 353 - 361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.